German, Danish Regulators Explain Dos And Don'ts Of Master Protocols
Executive Summary
Senior regulators from Germany's Federal Institute for Drugs and Medical Devices and the Danish Medicines Agency explain how sponsors can keep documentation and governance manageable for complex trials.